Market Place
Sourcing Support
Immunis Completes Ph 1/2a Trial for Muscle Atrophy
19 Nov 2024 //
BUSINESSWIRE
Immunis Starts Preclinical Studies on Canine Muscle Atrophy
04 Nov 2024 //
BUSINESSWIRE
Vaccine bond raises $1 bln for immunisations after record demand
24 Oct 2024 //
REUTERS
FDA Clears Immunis` Phase II Sarcopenic Obesity Trial
10 Sep 2024 //
BUSINESSWIRE
Immunis And Springbok Partner To Assess IMMUNA For Sarcopenia
25 Jul 2024 //
BUSINESSWIRE
Immunis Appoints Dr. Christina Weng to its Advisory Board
28 Jun 2024 //
BUSINESSWIRE
Immunis Partners with Japanese Drug Company Toray to Reverse Sarcopenia
22 May 2024 //
BUSINESSWIRE
Immunis Discusses with Experts Why the Immune System is the Key to Healthspan
05 Apr 2024 //
BUSINESSWIRE
Immunis Publishes Research Showing Secretomes Improve Metabolism &
19 Mar 2024 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead to Present Abundance360 Moonshot
18 Mar 2024 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead is an Invited Speaker at Conference
23 Feb 2024 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead to Speak at the Longevity Investors Lunch
08 Jan 2024 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead to Present at the 2024 Biotech Showcase
04 Jan 2024 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead is Honored As One of OCBJ’s OC500
21 Dec 2023 //
BUSINESSWIRE
Immunis Wins BASA Biotech Awards: “Best Small Business” & “Best Entrepreneur”
20 Dec 2023 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead to Present at BIO Europe Conference
27 Oct 2023 //
BUSINESSWIRE
Immunis is a Finalist for Best of America Small Business Awards – Vote for Us!!!
25 Oct 2023 //
BUSINESSWIRE
Immunis CBO Mark Cabato to Deliver Keynote at Drug Discovery Strategic Summit
11 Oct 2023 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead to Present at Innovative Therapies Days
09 Oct 2023 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead to Present at Festival of Biologics in Basel
26 Sep 2023 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead to Present at Advanced Therapies in Portugal
21 Aug 2023 //
BUSINESSWIRE
Immunis is a Finalist for High Tech Award for “Best Emerging Technology Company”
18 Aug 2023 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead to Speak at Ending Age-Related Diseases Summit
09 Aug 2023 //
BUSINESSWIRE
Immunis’ Phase 1/2a Approved by Data Safety and Monitoring Board to Proceed with Dose Escalation
01 Aug 2023 //
BUSINESSWIRE
Immunis Nominated for Prix Galien Award for “Best Startup”
27 Jul 2023 //
BUSINESSWIRE
Immunis Releases Article Highlighting the Potential of Cell Secretome Therapies
26 Jul 2023 //
BUSINESSWIRE
Immunis Releases Video Showcasing its Advanced Biotech Infrastructure
12 Jul 2023 //
BUSINESSWIRE
Immunis Appoints Neil Sahota as Chief Artificial Intelligence Officer
14 Apr 2023 //
BUSINESSWIRE
